Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,090 across all filing types
Latest filing 2022-11-23 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an offer period. It details positions and dealings in the securities of Mediclinic International plc by Citadel Group. This type of filing is a specific regulatory disclosure regarding major shareholdings and market activity during an M&A process, which falls under the 'Major Shareholding Notification' category.
2022-11-23 English
Form 8.3 - Mediclinic International plc
Regulatory Filings Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the UK Takeover Code for persons with interests in relevant securities representing 1% or more during an offer period. It details positions and dealings in the securities of Mediclinic International plc by Citadel Group. Since this is a specific regulatory disclosure form related to takeover activity and shareholding positions, it falls under the 'Regulatory Filings' (RNS) category as it does not fit into the specific 'Major Shareholding Notification' (MRQ) category (which usually refers to TR-1 filings) or 'Director's Dealing' (DIRS).
2022-11-22 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the 'Public Opening Position Disclosure/Dealing Disclosure' by a person with interests in relevant securities representing 1% or more. This type of document is specifically used for major shareholding notifications and disclosures related to takeover activity, which falls under the 'Major Shareholding Notification' category.
2022-11-21 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree company. It details positions and dealings in the securities of Mediclinic International plc by Citadel Group. This type of filing is a specific regulatory disclosure regarding shareholdings and market activity during a takeover period, which falls under the 'Major Shareholding Notification' category.
2022-11-18 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the 'Public Opening Position Disclosure/Dealing Disclosure' by a person with interests in relevant securities (Citadel Group) regarding Mediclinic International plc. This type of document is specifically used to report significant shareholding changes and dealings during an M&A process. While it relates to M&A activity, it is a specific regulatory disclosure form rather than a general M&A announcement (TAR). Therefore, it is best classified as a Major Shareholding Notification (MRQ) as it tracks ownership thresholds and dealings.
2022-11-17 English
Form 8.3 - Mediclinic International plc
Major Shareholding Notification Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory requirement under the UK Takeover Code for persons with interests in relevant securities representing 1% or more of an offeror or offeree. It details positions and dealings in the securities of Mediclinic International plc. Since this is a specific regulatory disclosure regarding shareholdings and dealings during a takeover period, it falls under the 'Major Shareholding Notification' category, which covers notifications of significant ownership levels and related disclosures.
2022-11-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.